We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Human immunoglobulin for diabetic amyotrophy--a promising prospect?
- Authors
Courtney, A. E.; McDonnell, G. V.; Patterson, V. H.
- Abstract
Diabetic neuropathies are universally recognised and cause significant morbidity. At present improving glycaemic control is the only recognised treatment. A man with type 2 diabetes presented with disabling asymmetric lower limb proximal neuropathy. Rapid clinical, functional, and electrical improvement followed treatment with intravenous immunoglobulin. The aetiology of diabetic amyotrophy remains controversial but there is evidence for an immune mediated process and this case suggests a role for immunoglobulin in the management of this debilitating condition.
- Subjects
PEOPLE with diabetes; MUSCULAR atrophy; IMMUNOGLOBULINS; DIABETES; GLOBULINS; NEUROMUSCULAR diseases; DIAGNOSIS of diabetic neuropathies; THERAPEUTIC use of immunoglobulins; INSULIN therapy; HYPOGLYCEMIC agents; COMBINATION drug therapy; DIABETIC neuropathies; ELECTROMYOGRAPHY; TYPE 2 diabetes; TREATMENT effectiveness
- Publication
Postgraduate Medical Journal, 2001, Vol 77, Issue 907, p326
- ISSN
0032-5473
- Publication type
journal article
- DOI
10.1136/pmj.77.907.326